Ansari, David <br/><br/>
Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.  [electronic resource] 

 -  Journal of the American Heart Association  Dec 2015 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.115.002790  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Antibodies, Monoclonal--adverse effects<br/>Antilymphocyte Serum--adverse effects<br/>Basiliximab<br/>Cause of Death<br/>Chi-Square Distribution<br/>Child<br/>Child, Preschool<br/>Databases, Factual<br/>Female<br/>Heart Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Induction Chemotherapy<br/>Kaplan-Meier Estimate<br/>Male<br/>Multivariate Analysis<br/>Proportional Hazards Models<br/>Recombinant Fusion Proteins--adverse effects<br/>Registries<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Tissue and Organ Procurement<br/>Treatment Outcome<br/>United States